Literature DB >> 15786693

Preventing sexual transmission of HIV: anti-HIV bioregulatory and homeostatic components of commercial sexual lubricants.

D Nguyen1, H Lee, J Poast, M W Cloyd, S Baron.   

Abstract

Certain safe over-the-counter (OTC) sexual lubricants such as Astroglide, KY Liquid, Replens, Vagisil, ViAmor, and Wet Stuff inhibit both cell-free HIV and the production of HIV by infected leukocytes in vitro even in the presence of seminal fluid. To identify which components of the lubricants were active against HIV, we tested five components (glycerin, methylparaben, propylparaben, polyquaternium-32, and propylene glycol). The paraben preservatives and propylene glycol in the lubricants did not inhibit HIV, while the common natural homeostatic metabolite, glycerin, and the thickener polyquaternium-32 did strongly inactivate infectious HIV and HIV-infected leukocytes. Activity against HIV and HIV-infected cells by glycerin was stable through 24 hours at 37 degrees C. Glycerin and polyquaternium-32 were active at minimum concentrations of approximately 2% and 0.01%, respectively--well within the highest FDA safety guidelines. Both active components disrupted infected leukocytes within 5 minutes which resulted in inhibition of infectious HIV production by infected leukocytes of greater than 25 to 100-fold. These components do not disrupt vaginal epithelial cells in vivo. These components also rapidly inactivate cell-free HIV by 10- to 30-fold. Thus, we may conclude that the active components of the OTC lubricants are glycerin and polyquaternium-32. Using these components, OTC sexual lubricants could be reformulated to optimize their anti-HIV activity. Furthermore, clinical trials of these lubricants and components seem to be indicated because of their FDA safety level, wide availability, and low cost.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15786693

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  7 in total

1.  Quantitative perceptual differences among over-the-counter vaginal products using a standardized methodology: implications for microbicide development.

Authors:  Ellen D Mahan; Kathleen M Morrow; John E Hayes
Journal:  Contraception       Date:  2011-01-07       Impact factor: 3.375

2.  Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.

Authors:  Barbra A Richardson; Cliff Kelly; Gita Ramjee; Thomas Fleming; Bonus Makanani; Sarah Roberts; Petina Musara; Nkhafwire Mkandawire; Thomas Moench; Anne Coletti; Lydia Soto-Torres; Salim A Karim
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

3.  Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.

Authors:  Nancy S Padian; Ariane van der Straten; Gita Ramjee; Tsungai Chipato; Guy de Bruyn; Kelly Blanchard; Stephen Shiboski; Elizabeth T Montgomery; Heidi Fancher; Helen Cheng; Michael Rosenblum; Mark van der Laan; Nicholas Jewell; James McIntyre
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321

4.  Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity.

Authors:  Charlene S Dezzutti; Elizabeth R Brown; Bernard Moncla; Julie Russo; Marilyn Cost; Lin Wang; Kevin Uranker; Ratiya P Kunjara Na Ayudhya; Kara Pryke; Jim Pickett; Marc-André Leblanc; Lisa C Rohan
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

5.  Topical microbicides to prevent the transmission of HIV: formulation gaps and challenges.

Authors:  Jim A Turpin
Journal:  Drug Deliv Transl Res       Date:  2011-05-21       Impact factor: 4.617

6.  Rectal application of a highly osmolar personal lubricant in a macaque model induces acute cytotoxicity but does not increase risk of SHIV infection.

Authors:  Sundaram A Vishwanathan; Monica R Morris; Richard J Wolitski; Wei Luo; Charles E Rose; Dianna M Blau; Theodros Tsegaye; Sherif R Zaki; David A Garber; Leecresia T Jenkins; Tara C Henning; Dorothy L Patton; R Michael Hendry; Janet M McNicholl; Ellen N Kersh
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

7.  Repeated rectal application of a hyperosmolar lubricant is associated with microbiota shifts but does not affect PrEP drug concentrations: results from a randomized trial in men who have sex with men.

Authors:  Richard E Haaland; Jeffrey Fountain; Yingtian Hu; Angela Holder; Chuong Dinh; LaShonda Hall; Nicole A Pescatore; Sheila Heeke; Clyde E Hart; Jiahui Xu; Yi-Juan Hu; Colleen F Kelley
Journal:  J Int AIDS Soc       Date:  2018-10       Impact factor: 5.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.